« Previous
Next »
European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 145, Issue 1
, Pages 22-26
, July 2009
Circulating microparticles, lupus anticoagulant and recurrent miscarriages
References
- . Recurrent miscarriage and inherited thrombophilia: diagnostic work-out and therapeutic management. Med Clin (Barc). 2005;125:626–631
- . Thrombosis in pregnancy: maternal and fetal issues. Lancet. 1999;353:1258–1265
- . Epidemiology of recurrent spontaneous abortion. Am J Reprod Immunol. 1991;26:23–27
- . Immunotherapy for recurrent spontaneous abortion and its analogies to treatment for cancer. Am J Reprod Immunol. 1991;25:114–119
- . Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia. Semin Repord Endocrinol. 1998;16:17–31
- . Endothelial cell perturbation by anti-phospholipid antibodies in systemic lupus erythematosus. Lupus. 2007;16(Suppl.):17–19
- Inflammatory response and the endothelium. Thromb Res. 2004;114:329–334
- . Tissue factor pathway and the antiphospholipid syndrome. J Autoimmun. 2000;15:217–220
- Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with severity of thrombosis. Arthritis Rheum. 2000;43:55–64
- . Pathogenic mechanisms of antiphospholipid syndrome: a new autoimmune disease. Drug Disc Today: Dis Mech. 2004;1:309–314
- . Microparticles as regulators of inflammation. Arthritis Rheum. 2005;52:3337–3348
- . The nature and significance of platelet products in human plasma. Br J Haematol. 1967;13:269–288
- . Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotophoblast microparticles. J Immunol. 2007;178:5949–5956
- . Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem. 1990;265:3809–3814
- . Apoptotic bodies from endothelial cells enhanced the number and initiate the differentiation of human endothelial progenitor cells in vitro. Blood. 2004;104:2761–2766
- . Follicular dendritic cells carry MHC class-II-expressing microvesicles at their surface. J Immunol. 2000;165:1259–1265
- . Exosome: from internal vesicle of the multivesicular body to intercellular signalling device. J Cell Sci. 2000;113:3365–3374
- Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell. 1995;80:919–927
- Endothelial and platelet microparticles in vascultis of the young. Arthritis Rheum. 2004;50:927–936
- . The release of microparticles by apoptoticcells and their effects on macrophages. Apoptosis. 2005;
- . Enrichment of two glyosyl-phosphatidylinositol-anchored proteins, acetylcholinenesterase and decay accelerating factor, in vesicles released from human red blood cells. Blood. 1989;74:1481–1485
- . Ca(++)-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin. Blood. 2002;99:2569–2577
- . Measuring circulating cell-derived microparticles. J Thromb Haemost. 2004;2:1842–1843
- . Inherited thrombophilia and gestational vascular complications. Semin Thromb Haemost. 2003;29:185–193
- . Lupus anticoagulants, anticardiolipin antibodies, and fetal loss: a case–control study. N Engl J Med. 1991;325:1063–1066
- . Antiphospholpid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol. 2003;101:1333–1448
- . Towards the understanding of heterogeneity of clinical manifestations related to antiphospholipid antibodies. Med Clin (Barc). 2005;125:187–189
- Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight. Thromb Haemost. 2001;85:18–21
- . Trnasmembrane phospholipids distribution in blood cells: control mechanism and pathophysiological significance. J Biol Chem. 1998;379:973–986
- . Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest. 1997;99:2118–2127
- . Endothelial cell activation by leukocyte microparticles. J Immunol. 1998;16:4382–4387
- Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation. 2000;101:841–848
- . Platelet-derived microvesicles in thrombotic thrombocytopenic purpura and haemolytic uremic syndromes. Thromb Haemost. 1996;75:427–431
- . Elevated endothelial microparticles in thrombotic trombocitopenic purpura: findings from brain and renal mirovascular cell culture and patients with active disease. Br J Haematol. 2001;112:81–90
- Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanism. Thromb Haemost. 2001;85:810–820
- Elevated plasma endothelial microparticles in multiple sclerosis. Neurology. 2001;56:1319–1324
- Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intra uterine growth restriction. Thromb Haemost. 2003;89:486–492
- Prevalence of circulating procoagulant microparticles in women with recurrent miscarriage: a case-controlled study. Hum Reprod. 2004;19:191–195
- In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest. 1999;104:93–102
- Phophatidylserine/phosphatidylcholine microvesicles can induce pre-eclampsia-like changes in pregnant mice. Semin Thromb Haemost. 2005;31:314–320
- . Isolated microparticles, but not whole plasma, from women with preeclampsia impair entothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women. Am J Obstet Gyneol. 2002;187
- . Endothelial cell microparticles and antiphospholipid syndrome: pathologic explanations and diagnostic opportunities. Thromb Haemost. 2004;91:636–638
- Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome. Thromb Haemost. 2004;91:667–673
- . Antibodies, thrombosis and the endothelium. Br J Rheumatol. 1996;33:2–5
- . Lupus anticoagulants are stronger risk factors of thrombosis than anticardiolipina antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003;101:1827–1832
- . TNF, apoptosis and autoimmunity a common threat?. Blood Cells Mol Dis. 1998;24:216–230
- . Endothelial microparticles in disease. Cell Tissue Res. 2009;335:143–151
- . Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphiospholipid antibodies. Thromb Res. 2007;121:319–325
- Circulating platelet-derived microparticles in systemic lupus erythematosus Association with increased thrombin generation and procoagulant state. Thromb Haemost. 2006;95:94–99
- Systemic changes in haemostatic balance are not associated with increased levels of circulating microparticles in women with recurrent spontaneous abortion. Am J Reprod Immunol. 2008;59:159–166
PII: S0301-2115(09)00246-2
doi: 10.1016/j.ejogrb.2009.04.002
© 2009 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 145, Issue 1
, Pages 22-26
, July 2009
